Early research (Phase 1)Ended earlyNCT02714374What this trial is testingGL-ONC1 Administered Intravenously Prior to Surgery to Patients With Solid Organ CancersWho this might be right forSolid Organ Cancers Andrew Lowy 5
Large-scale testing (Phase 3)Ended earlyNCT00031837What this trial is testingGemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic CancerWho this might be right forPancreatic CancerThromboembolism Gary Morrow 400
Testing effectiveness (Phase 2)Active Not RecruitingNCT04233866What this trial is testingComparing Two Treatment Combinations, Gemcitabine and Nab-Paclitaxel With 5-Fluorouracil, Leucovorin, and Liposomal Irinotecan for Older Patients With Pancreatic Cancer That Has SpreadWho this might be right forMetastatic Pancreatic AdenocarcinomaStage IV Pancreatic Cancer AJCC v8 ECOG-ACRIN Cancer Research Group 176
Testing effectiveness (Phase 2)Study completedNCT00003923What this trial is testingPhotodynamic Therapy in Treating Patients With Cancer of the Bile Duct, Gallbladder, or PancreasWho this might be right forExtrahepatic Bile Duct CancerGallbladder CancerLiver Cancer+1 more Memorial Sloan Kettering Cancer Center 4
Not applicableLooking for participantsNCT04907643What this trial is testingVirtual Reality for GI Cancer Pain to Improve Patient Reported OutcomesWho this might be right forCancer PainVisceral PainGastrointestinal Neoplasms+76 more Cedars-Sinai Medical Center 360
Testing effectiveness (Phase 2)Study completedNCT00112697What this trial is testingRadiation Therapy and Docetaxel With Either Fluorouracil or Cisplatin as First-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By SurgeryWho this might be right forPancreatic Cancer UNICANCER 71
Early research (Phase 1)Study completedNCT04132505What this trial is testingBinimetinib and Hydroxychloroquine in Treating Patients With KRAS Mutant Metastatic Pancreatic CancerWho this might be right forMetastatic Pancreatic AdenocarcinomaStage IV Pancreatic Cancer AJCC v8 M.D. Anderson Cancer Center 34
Not applicableStudy completedNCT00477919What this trial is testingE-MOSAIC Electronic Tool to Monitor SymptomsWho this might be right forCancer Swiss Cancer Institute 264
Testing effectiveness (Phase 2)Study completedNCT01488552What this trial is testingGemcitabine+Nab-paclitaxel and FOLFIRINOX and Molecular Profiling for Patients With Advanced Pancreatic CancerWho this might be right forStage IV Pancreatic Cancer Pancreatic Cancer Research Team 60
Early research (Phase 1)Study completedNCT00003411What this trial is testingRadiation Therapy in Treating Patients With Bile Duct, Gallbladder, or Pancreatic CancerWho this might be right forExtrahepatic Bile Duct CancerGallbladder CancerPancreatic Cancer University of Pittsburgh
Testing effectiveness (Phase 2)Study completedNCT00020345What this trial is testingCombination Chemotherapy and Radiation Therapy Plus Surgery in Treating Patients With Advanced Cancer of the PancreasWho this might be right forStage IVA Pancreatic CancerStage III Pancreatic CancerAdenocarcinoma of the Pancreas National Institutes of Health Clinical Center (CC)
Large-scale testing (Phase 3)Study completedNCT00425360What this trial is testingGemcitabine and Capecitabine With or Without Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Pancreatic CancerWho this might be right forPancreatic Cancer Royal Liverpool University Hospital 1,110
Testing effectiveness (Phase 2)Study completedNCT01658943What this trial is testingSelumetinib and Akt Inhibitor MK2206 or mFOLFOX Therapy Comprising Oxaliplatin and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer Previously Treated With ChemotherapyWho this might be right forPancreatic Acinar Cell CarcinomaPancreatic Ductal AdenocarcinomaRecurrent Pancreatic Carcinoma+1 more National Cancer Institute (NCI) 137
Testing effectiveness (Phase 2)Study completedNCT00962312What this trial is testingLapatinib Ditosylate and Capecitabine in Treating Patients With Metastatic Pancreatic CancerWho this might be right forPancreatic Cancer Cancer Trials Ireland 9
Very early researchLooking for participantsNCT07089940What this trial is testingOMO-103 for the Treatment of Locally Advanced or Metastatic Pancreatic Ductal AdenocarcinomaWho this might be right forLocally Advanced Pancreatic Ductal AdenocarcinomaMetastatic Pancreatic Ductal AdenocarcinomaStage II Pancreatic Cancer AJCC v8+2 more OHSU Knight Cancer Institute 12
Not applicableStudy completedNCT03222258What this trial is testingProspective Cohort Study Depending on the Use of Palliative Care for Advanced Stage of Cancer PatientsWho this might be right forStage IV Breast CancerStage IV Pancreatic CancerStage IV Colon Cancer+9 more Seoul National University Hospital 444
Testing effectiveness (Phase 2)Ended earlyNCT00625586What this trial is testingMonoclonal Antibody RAV12 and Gemcitabine in Treating Patients With Metastatic Pancreatic CancerWho this might be right forPancreatic Cancer MacroGenics 2
Early research (Phase 1)Study completedNCT00002854What this trial is testingHigh-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced CancerWho this might be right forCancer City of Hope Medical Center 33
Testing effectiveness (Phase 2)Active Not RecruitingNCT05642962What this trial is testingPancrelipase in People With Pancreatic Ductal Adenocarcinoma (PDAC)Who this might be right forMetastatic Pancreatic Ductal AdenocarcinomaMetastatic Pancreatic CancerMetastatic Pancreatic Adenocarcinoma+10 more Memorial Sloan Kettering Cancer Center 17
Not applicableStudy completedNCT03620461What this trial is testingGemcitabine and Nabpaclitaxel in Metastatic Pancreatic Carcinoma.Who this might be right forMetastatic Pancreatic Cancer Galician Research Group on Digestive Tumors 210